Skip to main content
SpringerLink
Log in

Epstein-Barr Virus

  • Chapter
Viral Diseases in Pregnancy

Part of the book series: Clinical Perspectives in Obstetrics and Gynecology ((CPOG))

  • 119 Accesses

Abstract

Epstein-Barr virus (EBV) was discovered growing in cultured lymphoblasts derived from patients with Burkitt’s lymphoma in 1964.1 Serologic evidence presented in 1966 also suggested a relationship between EBV and nasopharyngeal carcinoma.2 Subsequently, in 1968 EBV was demonstrated to be the causative agent of infectious mononucleosis.3 Now EBV is recognized to be a ubiquitous agent, with more than 95% of the adult population worldwide having serologic evidence of exposure.4

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet. 1964; 1: 702–703.

    Article  PubMed  CAS  Google Scholar 

  2. Old LJH, Boyse EA, Oettgen HF, et al. Precipitating antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proc Natl Acad Sei USA. 1966; 56: 1699–1704.

    Article  CAS  Google Scholar 

  3. Henle G, Henle W, Diehl V. Relation of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sei USA. 1968; 59: 94–101.

    Article  CAS  Google Scholar 

  4. Le CT, Chang RS, Lipson MH. Epstein-Barr virus infections during pregnancy: A prospective study and review of the literature. Am J Dis Child. 1983; 137: 466–468.

    PubMed  CAS  Google Scholar 

  5. Baer R, Bankier AT, Biggin MD, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 1984; 310: 207–211.

    Article  PubMed  CAS  Google Scholar 

  6. Sixbey JW, Nedrud JG, Raab-Traub N, et al. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med. 1984; 310: 1225–1230.

    Article  PubMed  CAS  Google Scholar 

  7. Wolf H, Haus M, Wilmes E. Persistence of Epstein-Barr virus in the parotid gland. J Virol. 1984; 51: 795–798.

    PubMed  CAS  Google Scholar 

  8. Allday M J, Crawford DH. Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet. 1988; 1: 855–857.

    Article  PubMed  CAS  Google Scholar 

  9. Sixbey JW, Lemon SM, Pagano JS. A second site for Epstein-Barr virus shedding: The uterine cervix. Lancet. 1986; 2: 1122–1124.

    Article  PubMed  CAS  Google Scholar 

  10. Fingeroth JD, Weis JJ, Tedder TF, et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sei USA. 1984; 81: 4510–4514.

    Article  CAS  Google Scholar 

  11. McClure JE. Cellular receptor for Epstein- Barr virus. Prog Med Virol 1992; 39: 116–138.

    PubMed  CAS  Google Scholar 

  12. Delcayre AX, Salas F, Mathur S, et al. Epstein-Barr virus/complement C3d receptor is an interferon alpha receptor. EMBO J. 1991; 10: 919–926.

    PubMed  CAS  Google Scholar 

  13. Tanner J, Weis J, Fearon D, et al. Epstein- Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell. 1987;50:203– 213.

    Article  PubMed  Google Scholar 

  14. Tosato G. The Epstein-Barr virus and the immune system. In: Klein G, Weihouse S, eds. Advances in Cancer Research. London: Academic Press; 1987: 49–75.

    Google Scholar 

  15. Kieff E, Liebowitz D. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, eds. Virology. New York: Raven Press; 1990: 1889–1920.

    Google Scholar 

  16. Sample C, Kieff E. Molecular basis for Epstein-Barr virus induced pathogenesis and disease. Springer Semin Immunopathol. 1991; 13: 133–146.

    Article  PubMed  CAS  Google Scholar 

  17. Rogers RP, Strominger JL, Speck SH. Epstein-Barr virus in B lymphocytes: Viral gene expression and function in latency. Adv Cancer Res. 1992; 58: 1–26.

    Article  PubMed  CAS  Google Scholar 

  18. Hudson GS, Bankier AT, Satchwell SC, et al. The short unique region of the B95-8 Epstein-Barr virus genome. Virology. 1985; 147: 81–98.

    Article  PubMed  CAS  Google Scholar 

  19. Sugden B, Warren N. A promoter of Epstein- Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol. 1989; 63: 2644–2649.

    PubMed  CAS  Google Scholar 

  20. Wang D, Liebowitz D, Wang F, et al. Epstein-Barr virus latent infection membrane protein alters the human B lymphocyte phenotype: Deletion of the amino terminus abolishes activity. J Virol. 1988;62:4173– 4184.

    PubMed  CAS  Google Scholar 

  21. Wang F, Gregory C, Sample C, et al. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMPl cooperatively induce CD23. J Virol. 1990; 64: 2309–2318.

    PubMed  CAS  Google Scholar 

  22. Takada K, Ono Y. Synchronous and sequential activation of latently infected Epstein- Barr virus genomes. J Virol. 1989; 63: 445–504.

    PubMed  CAS  Google Scholar 

  23. Takada K, Horinouchi K, Ono Y, et al. An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA. Virus Genes. 1991; 5: 147–156.

    Article  PubMed  CAS  Google Scholar 

  24. Daibata M, Humphreys RE, Takada K, et al. Activation of latent EBV via anti-IgG- triggered, second messenger pathways in the Burkitt’s lymphoma cell line Akata. J Immunol. 1990; 144: 4788–4793.

    PubMed  CAS  Google Scholar 

  25. Sinclair AJ, Farrell PJ. Epstein-Barr virus transcription factors. Cell Growth Diff. 1992; 3: 557–563.

    PubMed  CAS  Google Scholar 

  26. Flemington E, Speck SH. Autoregulation of Epstein-Barr virus BZLFl putative lytic switch gene BZLF 1. J Virol. 1990;64:1227– 1232.

    PubMed  Google Scholar 

  27. Sinclair AJ, Brimmell M, Shanahan F, et al. Pathways of activiation of the Epstein-Barr virus productive cycle. J Virol. 1991;65:2237– 2244.

    PubMed  Google Scholar 

  28. Hardwick JM, Lieberman PM, Hayward SD. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J Virol. 1988; 62: 2274–2284.

    PubMed  CAS  Google Scholar 

  29. Flemington EK, Goldfeld AE, Speck SH. Efficient transcription of the Epstein-Barr virus immediate-early BZLFl and BRLFl genes requires protein synthesis. J Virol. 1991; 65: 7073–7077.

    PubMed  CAS  Google Scholar 

  30. Meilinghoff I, Daibata M, Humphreys RE, et al. Early events in Epstein-Barr virus genome expression after activation-Regulation by second messengers of B cell activation. Virology. 1991; 185: 922–928.

    Article  Google Scholar 

  31. Kenney S, Holley-Guthrie E, Mar E-C, et al. The Epstein-Barr virus BMLFl promoter contains an enhancer element that is responsive to the BZLFl and BRLFl transac- tivators. J Virol. 1989; 63: 3878–3883.

    PubMed  CAS  Google Scholar 

  32. Holley-Guthrie EA, Quinlivan EB, Mar E-C, et al. The Epstein-Barr virus (EBV) BMRFl promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLFl and BZLFl, in a cell-specific manner. J Virol. 1990; 64: 3753–3759.

    PubMed  CAS  Google Scholar 

  33. Svedmyr E, Ernberg I, Seeley J, et al. Virologie, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis. Clin Immunol Immunopathol. 1984; 30: 437–450.

    Article  PubMed  CAS  Google Scholar 

  34. Sixbey J, Shirley P, Chesney P, et al. Detection of a second widespread strain of Epstein- Barr virus. Lancet. 1989; 2: 761–765.

    Article  PubMed  CAS  Google Scholar 

  35. Biggar R, Henle W, Fleisher G, et al. Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer. 1978;22:239– 243.

    Article  PubMed  CAS  Google Scholar 

  36. De-Thé G. Epidemiology of Epstein-Barr virus and associated diseases in man. In: Roizman B, ed. The Herpesviruses. New York: Plenum Press; 1982; 1: 25.

    Google Scholar 

  37. Paul JR, Bunnell WW. The presence of heterophil antibodies in infectious mononucleosis. Am J Med Sei. 1932; 183: 90–104.

    Article  Google Scholar 

  38. Pearson GR. Infectious mononucleosis: The humoral response. In: Schlossberg D, ed. Infectious Mononucleosis. New York: Springer- Verlag; 1989: 89–99.

    Google Scholar 

  39. Okano M, Thiele GM, Davis JR, et al. Epstein-Barr virus and human diseases: Recent advances in diagnosis. Clin Microbiol Rev. 1988; 1: 300–312.

    PubMed  CAS  Google Scholar 

  40. Gervais F, Joncas JH. Epstein-Barr virus infection: Seroepidemiology in various population groups of the greater Montreal area. Comp Immunol Microbiol Infect Dis. 1979; 2: 207–212.

    Article  PubMed  CAS  Google Scholar 

  41. Andersson JP. Clinical aspects of Epstein- Barr virus infections. Scand J Infect Dis. 1991;suppl 78:94–104.

    Google Scholar 

  42. Henle W, Henle G. Epstein-Barr virus specific serology in immunologically compromised individuals. Cancer Res. 1981;41:4222– 4228.

    Google Scholar 

  43. Rickinson AB. Cellular immunologic responses to the virus infection. In: Epstein MA, Achong BG, eds. The Epstein-Barr Virus: Recent Advances. New York: John Wiley; 1986: 75.

    Google Scholar 

  44. Wang F, Blaese RM, Zoon KC, et al. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis. J Clin Invest. 1987; 75: 7–14.

    Article  Google Scholar 

  45. Murray RJ, Wang G, Young LS, et al. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein. J Virol. 1988; 62: 3747–3755.

    PubMed  CAS  Google Scholar 

  46. Murray RJ, Kurilla MG, Griffin HM, et al. Human cytotoxic T cell responses against Epstein-Barr virus nuclear antigens demonstrated using recombinant vaccinia viruses. Proc Natl Acad Sei USA. 1990; 87: 2906–2910.

    Article  CAS  Google Scholar 

  47. Bejarano MT, Masucci M, Klein G, et al. T cell inhibition of EBV induced B cell transformation: Recognition of virus particles. Int J Cancer. 1988; 42: 359–364.

    Article  PubMed  CAS  Google Scholar 

  48. Bejarano MT, Masucci M, Morgan A, et al. Epstein-Barr virus (EBV) antigens processed and presented by B cells, B cell blasts, and macrophages trigger T cell mediated inhibition of EBV induced B cell transformation. J Virol. 1990; 64: 1398–1401.

    PubMed  CAS  Google Scholar 

  49. Misko IS, Sculley TB, Schmidt T, et al. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus specific component. Cell Immunol. 1991; 132: 295–307.

    Article  PubMed  CAS  Google Scholar 

  50. Moss DJ, Burrows SR, Khanna R, et al. Immune surveillance against Epstein-Barr virus. Semin Immunol. 1992; 4: 97–104.

    PubMed  CAS  Google Scholar 

  51. Hsu D-H,, de Waal Malefyt R, Fiorentino DF et al. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRFl. Science. 1990; 250: 830–832.

    Article  PubMed  CAS  Google Scholar 

  52. De Waal Malefyt R, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-present- ing capacity of monocytes via downregula- tion of class II major histocompatibility complex expression. J Exp Med. 1991;174:915– 924.

    Google Scholar 

  53. Moore KW, Rousset F, Banchereau J. Evolving principles in immunopathology: Interleukin 10 and its relationship to Epstein-Barr virus protein BCRFl. Springer Semin Immunopathol. 1991; 13: 157–166.

    Article  PubMed  CAS  Google Scholar 

  54. Moore KW, O’Garra A,, de Waal Malefyt R et al. Interleukin-10. Annu Rev Immunol. 1993; 11: 165–190.

    Article  PubMed  CAS  Google Scholar 

  55. Ornoy A, Dudai M, Sadovsky E. Placental and fetal pathology in infectious mononucleosis: A possible indicator for Epstein-Barr virus teratogenicity. Gynecol Obstet. 1982; 4: 11–16.

    CAS  Google Scholar 

  56. Wong SY, Sewell HF, MacGregor IE, et al. Epstein-Barr virus-A possible missing link in the initiation of cervical carcinogenesis? Med Hypotheses. 1991; 35: 219–222.

    Article  PubMed  CAS  Google Scholar 

  57. Israele V, Shirley P, Sixbey JW. Excretion of the Epstein-Barr virus from the genital tract of men. J Infect Dis. 1991; 163: 1341–1343.

    Article  PubMed  CAS  Google Scholar 

  58. Mroczek EC, Weisenburger DD, Lipscomb Grievson H, et al. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med. 1987; 111: 530–535.

    PubMed  CAS  Google Scholar 

  59. Sanguineti G, Crovato F, DeManchi R, et al. “Alice in Wonderland” syndrome in a patient with infectious mononucleosis. J Infect Dis. 1983; 147: 782.

    Article  PubMed  CAS  Google Scholar 

  60. Purtilo DT, Strobach RS, Okano M, et al. Biology of disease. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest. 1992; 67: 5–23.

    PubMed  CAS  Google Scholar 

  61. Strauss SE. Acute progressive Epstein-Barr virus infections. Annu Rev Med. 1992;43:437– 449.

    Google Scholar 

  62. Miller G, Grogan E, Rowe D, et al. Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection. J Infect Dis. 1987; 156: 26.

    Article  PubMed  CAS  Google Scholar 

  63. Schooley RT, Carey RW, Miller G, et al. Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serological features and response to antiviral chemotheraphy. Ann Intern Med. 1986; 104: 636.

    PubMed  CAS  Google Scholar 

  64. Okano M, Matsumoto S, Osato T, et al. Severe chronic active Epstein-Barr virus infection syndrome. Clinc Microbiol Rev. 1991; 4: 129–135.

    CAS  Google Scholar 

  65. Gaffey MJ, Weiss LM. Association of Epstein-Barr virus with human neoplasia. Pathol Annu. 1992; 27: 55–74.

    PubMed  Google Scholar 

  66. Lam KM, Whittle H, Crawford P. Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet. 1991; 1: 876–878.

    Article  Google Scholar 

  67. Whittle HC, Brown J, Marsh K, et al. T-cell control of Epstein-Barr virus-infected cells is lost during P. falciparum malaria. Nature. 1984; 312: 449–450.

    Article  PubMed  CAS  Google Scholar 

  68. Bernheim A, Berger R, Lenoir G. Cytogenetic studies on African Burkitt’s lymphoma cell lines: t(8; 14), t(2; 8) and t(8; 22) translocations. Cancer Genet Cytogenet. 1981; 3: 307–315.

    Article  PubMed  CAS  Google Scholar 

  69. Croce CM, Nowell PC. Molecular genetics of human B cell neoplasia. Adv Immunol. 1985; 38: 245–274.

    Article  Google Scholar 

  70. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 1986; 47: 883–889.

    Article  PubMed  CAS  Google Scholar 

  71. Manolov G, Manolova Y. Marker bank in one chromosome 14 from Burkitt’s lymphomas. Nature. 1972; 237: 33–34.

    Article  PubMed  CAS  Google Scholar 

  72. Aya T, Kinoshita T, Imai S, et al. Chromosome translocation and c-myc activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes. Lancet. 1991; 1: 1190.

    Article  Google Scholar 

  73. Parkin DM, Stjemsward J, Muir CS. Estimates for the worldwide frequency of twelve major cnacers. Bull WHO. 1984; 62: 163–182.

    PubMed  CAS  Google Scholar 

  74. Ho JHC. The natural history and treatment of nasopharyngeal carcinoma (NPC). Oncol Year Book. 1970; 4: 1–14.

    Google Scholar 

  75. Ablashi BV, Allal M, Armstrong G, et al. Some characteristics of nasopharyngeal carcinoma in Algeria. In: Grundman E, Krueger GRF, Albashi DV, eds. Cancer Campaign. New York: Gustav Fischer Verlag; 1981: 5167–5175.

    Google Scholar 

  76. Fahraeus R, Fu H-L, Ernberg I, et al. Expression of Epstein-Barr virus encoded proteins in nasopharyngeal carcinoma. Int J Cancer. 1988; 42: 329–338.

    Article  PubMed  CAS  Google Scholar 

  77. Young LS, Dawson CW, Clark D, et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol. 1988; 69: 1051–1065.

    Article  PubMed  CAS  Google Scholar 

  78. Zeng Y, Liu YX, Wei JN, et al. Serological mass survey of nasopharyngeal carcinoma. Chung Kuol Hsueh Yuan Hsueh Pao. 1979; 1: 123–126.

    CAS  Google Scholar 

  79. Zeng Y, Zhong JM, Li LY et al. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China. Intervirology. 1983; 20: 190–194.

    Article  PubMed  CAS  Google Scholar 

  80. Pearson GR, Weiland LH, Neel HB, et al. Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer. 1983; 51: 260–268.

    Article  PubMed  CAS  Google Scholar 

  81. Tam JS, Murray HGS. Nasopharyngeal carcinoma and Epstein-Barr virus-associated serologic markers. Ear Nose Throat J. 1990; 69: 261–267.

    PubMed  CAS  Google Scholar 

  82. Purtilo DT, Cassel C, Yang JP, et al. X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease). Lancet. 1975; 1: 935–941.

    Article  PubMed  CAS  Google Scholar 

  83. Purtilo DT, DeFlorio D Jr, Huff LM, et al. Variable phenotypic expression of an X-linked lymphoproliferative syndrome. N Engl J Med. 1977; 297: 1077–1081.

    Article  PubMed  CAS  Google Scholar 

  84. Skare JC, Grierson HL, Sullivan JL, et al. Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DXS42 and DXS37. Hum Genet. 1989;82:354– 358.

    Google Scholar 

  85. Itin PH, Rufli T. Oral hairy leukoplakia. Int J Dermatol. 1992; 31: 301–306.

    Article  PubMed  CAS  Google Scholar 

  86. Schiodt M, Greenspan D, Daniels TE, et al. Clinical and histologic spectrum of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1987; 64: 716–720.

    Article  PubMed  CAS  Google Scholar 

  87. Greenspan D, Greenspan JS, Hearst NG, et al. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis. 1987; 155: 475–481.

    Article  PubMed  CAS  Google Scholar 

  88. Greenspan JS, Greenspan D, Lennette ET. Replication of Epstein-Barr virus within the epithelial cells of oral hairy leukoplakia, an AIDS-associated lesion. N Engl J Med. 1985; 312: 1564–1571.

    Article  Google Scholar 

  89. Gilligan K, Rajadurai P, Resnick L, et al. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sei USA. 1990; 87: 8790–8794.

    Article  CAS  Google Scholar 

  90. Hitt MM, Allday MJ, Hara T, et al. EBV gene expression in an NPC-related tumour. EMBO J. 1989; 8: 2639–2651.

    PubMed  CAS  Google Scholar 

  91. Mueller N, Evans A, Harris NL, et al. Hodgkin’s disease and Epstein-Barr virus: Altered antibody pattern before diagnosis. N Engl J Med. 1989; 320: 689–695.

    Article  PubMed  CAS  Google Scholar 

  92. Herbst H, Pallesen G, Weiss LM, et al. Hodgkin’s disease and Epstein-Barr virus. Ann Oncol. 1992; 3 (suppl 4): 527–530.

    Google Scholar 

  93. Weiss LM, Movahed LA, Warnke RA, et al. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med. 1989; 320: 502–506.

    Article  PubMed  CAS  Google Scholar 

  94. Herbst H, Niedobitek G, Kneba M, et al. High incidence of Epstein-Barr virus genomes in Hodgkin’s disease. Am J Pathol. 1990; 137: 13–18.

    PubMed  CAS  Google Scholar 

  95. Wright C, Ventre K, Tsai M, et al. Epstein- Barr virus related sequence in formalin- fixed, paraffin-embedded tissue: Identification by polymerase chain reaction amplification. Lab Invest. 1990; 62: 108–113.

    Google Scholar 

  96. Anagnostopoulos I, Herbst H, Niedobitek G, et al. Demonstration of monoclonal EBV genomes in Hodgkin’s disease and Ki-1 positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood. 1989; 74: 810–816.

    PubMed  CAS  Google Scholar 

  97. Cohen JI. Epstein-Barr virus lymphoproli- ferative disease associated with acquired immunodeficiency. Medicine (Baltimore). 1991; 70: 137–160.

    Article  CAS  Google Scholar 

  98. Subar M, Neri A, Inghirami G, et al. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood. 1988; 72: 667–671.

    PubMed  CAS  Google Scholar 

  99. Borisch-Chappuis B, Nezelof C, Muller H, et al. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients. Am J Pathol. 1990; 136: 751–758.

    PubMed  CAS  Google Scholar 

  100. Schuster V, Kreth HW. Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects. Eur J Pediatr. 1992; 151: 718–725.

    Article  PubMed  CAS  Google Scholar 

  101. Andersson M, Klein G, Ziegler JL, et al. Association of Epstein-Barr viral genomes with American Burkitt lymphoma. Nature. 1976; 260: 357–359.

    Article  PubMed  CAS  Google Scholar 

  102. Cleary ML, Warnke R, Sklar J. Monoclo- nality of lymphoproliferative lesions in cardiac-transplant recipients. N Engl J Med. 1984; 310: 477–482.

    Article  PubMed  CAS  Google Scholar 

  103. Shapiro RS, Chauvenet A, McGuire W, et al. Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. N Engl J Med. 1988; 315: 1334.

    Google Scholar 

  104. Fleisher G, Bologonese R. Epstein-Barr virus infections in pregnancy: A prospective study. J Pediatr. 1984; 104: 364–379.

    Google Scholar 

  105. Hunter K, Stagno S, Capps E, et al. Prenatal screening of pregnant women for infections caused by cytomegalovirus, Epstein-Barr virus, herpesvirus, rubella, and Toxoplasmosis gondii. Am J Obstet Gynecol. 1983;145:269– 273.

    PubMed  CAS  Google Scholar 

  106. Icart J, Didier J, Dalens M, et al. Prospective study of Epstein-Barr virus (EBV) infection during pregnancy. Biomedicine. 1981; 34: 160–163.

    PubMed  CAS  Google Scholar 

  107. Fleisher G, Bolognese R. Persistent Epstein -Barr virus infection and pregnancy. J Infect Dis. 1983; 147: 982–986.

    Article  PubMed  CAS  Google Scholar 

  108. Waterson AP. Virus infection (other than rubella) during pregnancy. Br Med J. 1979; 2: 564–566.

    Article  PubMed  CAS  Google Scholar 

  109. Costa S, Barrasso R, Terzano P, et al. Detection of active Epstein-Barr infection in pregnant women. Eur J Clin Microbiol. 1985; 4: 335–336.

    Article  PubMed  CAS  Google Scholar 

  110. Sakamoto K, Greally J, Gilfillan RF, et al. Epstein-Barr virus in normal pregnant women. Am J Reprod Immunol. 1982; 2: 217–221.

    PubMed  CAS  Google Scholar 

  111. Icart J, Didier J. Infections due to Epstein-Barr virus during pregnancy. J Infect Dis. 1981; 143: 499.

    Article  PubMed  CAS  Google Scholar 

  112. Fleisher G, Bologonese R. Infectious mononucleosis during gestation: Report of three women and their infants studied prospectively. Pediatr Infect Dis. 1984; 3: 308–311.

    Article  PubMed  CAS  Google Scholar 

  113. Miller HC, Clifford SH, Smith CA, et al. Study of the relationship of congenital malformation to maternal rubella and other infections: Preliminary report. Pediatrics. 1949; 3: 259–270.

    PubMed  CAS  Google Scholar 

  114. Niederman JC, McCollum RW, Henle G, et al. Infectious mononucleosis. Clinical manifestations in relation to EBV antibodies. JAMA. 1968; 203: 205–212.

    Article  PubMed  CAS  Google Scholar 

  115. Tallqvist H, Henle W, Klemula E, et al. Antibody to EBV at the ages of 6–33 months in children with congenital heart disease. Scand J Infect Dis. 1973; 159: 161.

    Google Scholar 

  116. Harris RE. Viral teratogenesis. A review with experimental and clinical perspective. Am J Obstet Gynecol. 1974; 119: 996–1008.

    PubMed  CAS  Google Scholar 

  117. Goldberg GN, Fulginiti VA, Ray CG, et al. In utero Epstein-Barr virus (infectious mononucleosis) infection. JAMA. 1981;246:1579– 1581.

    PubMed  Google Scholar 

  118. Leary DC, Welt LG, Beckett RS. Infectious mononucleosis during pregnancy with fatal congenital anomaly of infant. Am J Obstet Gynecol. 1949; 56: 381–384.

    Google Scholar 

  119. Brown ZA, Stenchever MA. Infectious mononucleosis and congential anomalies. Am J Obstet Gynecol. 1978; 131: 108–109.

    PubMed  CAS  Google Scholar 

  120. Visintine AM, Gerber P, Nahmias AJ. et al. Leukocyte transforming agent (Epstein-Barr virus) in newborn infants and older individuals. J Pediatr. 1976; 89: 571–575.

    Article  PubMed  CAS  Google Scholar 

  121. Horwitz Ca, McClain K, Henle W, et al. Fatal illness in a 2-week-old infant: Diagnosis by detection of Epstein-Barr virus genomes from a lymph node biopsy. J Pediatr. 1983; 103: 752–755.

    Article  PubMed  CAS  Google Scholar 

  122. Weaver LT, Nelson R, Bell TM. The association of extrahepatic bile duct atresia and neonatal Epstein-Barr virus infection. Acta Paediatr Scand. 1984; 73: 155–157.

    Article  PubMed  CAS  Google Scholar 

  123. Henle W, Henle G. Immunology of Epstein- Barr virus. In: Roizman B, ed. the Herpesviruses. New York: Plenum Press; 1982; 1: 209.

    Google Scholar 

  124. Sumaya CV. Endogenous reactivation of Epstein-Barr virus infections. J Infect Dis. 1977; 135: 374.

    Article  PubMed  CAS  Google Scholar 

  125. Andersson J, Ernberg I. Management in Epstein-Barr virus infections. Am J Med. 1988; 88 (suppl 2A): 108–115.

    Google Scholar 

  126. Wielaard F, Scherders J, Dagelinckx C, et al. Development of an antibody-capture IgM- enzyme-linked immunoassay for diagnosis of acute Epstein-Barr virus infections. J Virol Methods. 1988; 21: 105–115.

    Article  PubMed  CAS  Google Scholar 

  127. Linde A, Kallin B, Dillner J, et al. Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. J Infect Dis. 1990; 161: 903–909.

    Article  PubMed  CAS  Google Scholar 

  128. Strauss SE, Cohen JI, Tosato G, et al. Epstein-Barr virus infection: Biology, pathogenesis, and management. Ann Intern Med. 1993; 118: 45–58.

    Google Scholar 

  129. Chang RS, Blankenship W. Spontaneous in vitro transformation of leukocytes from a neonate. Proc Soc Exp Biol Med. 1973; 144: 337.

    PubMed  CAS  Google Scholar 

  130. Pagano JS. Detection of Epstein-Barr virus with molecular hybridization techniques. Rev Infect Dis. 1991; 13 (suppl 1): 5123–5128.

    Article  Google Scholar 

  131. Sixbey JW, Shirley PS. Viral diagnosis using DNA-based probes. Enzymatic amplification of target DNA. Ann NY Acad Sci. 1988; 549: 158.

    Article  PubMed  CAS  Google Scholar 

  132. Strauss SE. Epstein-Barr virus and human herpesvirus type 6. In: Galasso GJ, Whitely RJ, Merigan TC, eds. Antiviral Agents and Viral Diseases of Man. 3rd ed. New York: Raven Press; 1990: 647–668.

    Google Scholar 

  133. Pagano JS, Sixbey JW, Lin JC. Acyclovir and Epstein-Barr virus infection. J Antimicrob Chemother. 1983; 12 (suppl B): 113–121.

    PubMed  Google Scholar 

  134. Andersson J, Britton S, Ernberg I, et al. Effect of acyclovir on infectious mononucleosis: A double-blind, placebo-controlled study. J Infect Dis. 1986; 153: 283–290.

    Article  PubMed  CAS  Google Scholar 

  135. Andersson J, Skoldenberg B, Henle W, et al. Acyclovir treatment in infectious mononucleosis: A clinical and virological study. Infection. 1987; 15: 14–20.

    Article  Google Scholar 

  136. Van der Horst C, Joncas J, Ahronheim G, et al. Lack of effect of peroral acyclovir for the treatment of infectious mononucleosis. J Infect Dis. 1991; 164: 788–792.

    Article  PubMed  Google Scholar 

  137. Morgan AJ. Epstein-Barr virus vaccines. Vaccine. 1992; 10: 563–571.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Kenneth F. Trofatter Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Wayne State University School of Medicine, 6071 West Outer Drive, 48235, Detroit, MI, USA

    Bernard Gonik M.D. (Professor and Vice Chairman Chief of Obstetrics and Gynecology—Grace Hospital) (Professor and Vice Chairman Chief of Obstetrics and Gynecology—Grace Hospital)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Trofatter, K.F. (1994). Epstein-Barr Virus. In: Gonik, B. (eds) Viral Diseases in Pregnancy. Clinical Perspectives in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2640-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2640-6_7

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7620-3

  • Online ISBN: 978-1-4612-2640-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation